Results 211 to 220 of about 2,227,737 (406)
Prognostic value of N‐terminal pro C‐type natriuretic peptide in heart failure patients with preserved and reduced ejection fraction [PDF]
, 2014 Dirk J. Lok +8 more
openalex +1 more source
Advanced Microfluidic‐Based Wearable Electrochemical Sensors for Continuous Biochemical Monitoring
Advanced Electronic Materials, EarlyView.Microfluidic‐based wearable electrochemical sensors are transforming non‐invasive health monitoring through real‐time biochemical analysis of sweat, saliva, and interstitial fluid. This review explores advances in microfluidic design, fabrication, and sensor integration while addressing biofluid variability, material compatibility, and scalability.
Sehyun Park +5 more
wiley +1 more source
Clinical Cardiology, Volume 45, Issue 12, Page 1211-1219, December 2022., 2022 Abstract Background Elderly patients with ST‐elevation myocardial infarction (STEMI) who undergo percutaneous coronary intervention (PCI) are usually excluded from major trials. Hyopthesis This study sought to assess 1‐year clinical outcomes following PCI with a drug‐eluting stent in patients older than 80 years old with STEMI.
Majdi Saada +11 more
wiley +1 more source
Clinical Cardiology, Volume 45, Issue 12, Page 1229-1235, December 2022., 2022 Abstract Background Cryoballoon ablation (CBA) is recommended for patients with symptomatic drug refractory paroxysmal atrial fibrillation (pAF). However, substantial atrial fibrillation (AF) recurrence is common during follow‐up. Searching for a potential biomarker representing both myocardial injury and inflammation to identify patients at high risk ...
Xinxin Li +9 more
wiley +1 more source
Indian Heart Journal, 2020 Background: Acute decompensated heart failure (ADHF) is a growing public health problem in the community. Limited and often contradictory data are available from small studies published from India.
Sri Harsha Onteddu +3 more
doaj
Editorial: Edema in heart failure with reduced ejection fraction
Frontiers in Cardiovascular Medicine, 2023 Inna P. Gladysheva +2 more
openaire +3 more sources
Management of Chronic Heart Failure with Reduced Ejection Fraction
The Journal of the American Board of Family MedicineHeart failure with reduced ejection fraction (HFrEF) is a commonly seen clinical entity in the family physician's practice. This clinical review focuses on the pharmacologic management of chronic HFrEF. Special attention is paid to the classification of heart failure and the newest recommendations from the American Heart Association concerning the use ...
Brandon, Williamson, Carl, Tong
openaire +2 more sources
Cell Membrane‐Coated Lipid Nanoparticles for Drug Delivery
Aggregate, EarlyView.This review highlights recent progress in cell membrane‐coated lipid nanoparticles (CMC‐LNPs), focusing on their design, preparation methods, functional integration, and biomedical applications. It discusses various types of LNPs and coating strategies, characterization techniques, therapeutic functions, and applications.
Moataz B. Zewail +5 more
wiley +1 more source
Clinical Cardiology, Volume 45, Issue 12, Page 1163-1170, December 2022., 2022 Abstract The implantable cardiac defibrillator (ICD) is common for the management of nonischemic cardiomyopathy (NICM). Mortality is a crucial issue for patients with NICM. We can understand the mortality events of ICD versus medicine treatment via a systemic review and meta‐analysis of randomized clinical trials.
Wenfeng He +3 more
wiley +1 more source
Usefulness of Heart Failure Categories Based on Left Ventricular Ejection Fraction
Journal of the American Heart Association: Cardiovascular and Cerebrovascular DiseaseBackground Heart failure guidelines have recently introduced a narrow category with mildly reduced left ventricular ejection fraction (LVEF) (heart failure with mildly reduced ejection fraction; LVEF 41%–49%) between the previous categories of reduced ...
Malin Christersson +7 more
doaj +1 more source